臨牀消化器内科 Vol.15 No.5(4)


特集名 門脈圧亢進症
題名 肝性脳症
発刊年月 2000年 05月
著者 植松 孝広 岐阜大学医学部第一内科
著者 森脇 久隆 岐阜大学医学部第一内科
【 要旨 】 肝性脳症は,重篤な肝機能障害に基づいて二次的に意識障害をはじめとする多彩な精神神経症状をきたす症候群である.臨床的には急性型,慢性再発型,末期昏睡型に分類され,門脈圧亢進症では後二者が出現する.誘因は慢性再発型では便通異常,末期昏睡型では大量消化管出血が多い.発生機序はアンモニアをはじめとする腸管由来の有毒物質,アミノ酸インバランス,GABA作動性神経伝達の異常などが挙げられる.治療として誘因対策や合成二糖類,難吸収性抗生剤の投与とともに特殊組成アミノ酸輸液(Fischer液)を用いることにより,慢性再発型では98%以上の覚醒率が得られる.
Theme Portal Hypertension
Title Hepatic Encephalopathy
Author Takahiro Uematsu First Department of Internal Medicine, Gifu University School of Medicine
Author Hisataka Moriwaki First Department of Internal Medicine, Gifu University School of Medicine
[ Summary ] Hepatic encephalopathy is a syndrome with a wide variety of neuropsychiatric manifestations, due to severe hepatic insufficiency. The clinical classifications of hepatic encephalopathy include; 1) the acute type which is typical in fuluminant hepatitis, 2-a) the endstage coma type and 2-b) the chronic recurrent type, both end stage coma and 2-b chronic recurrent types are seen in portal hypertension. Encephalopathy is often preceded by constipation in the chronic recurrent type and by severe gastrointestinal bleeding in the endstage coma type. This syndrome is caused by toxins produced in the gut such as ammonia, an imbalance of plasma amino acids, and increased GABA-mediated neurotransmission. Treatment of this syndrome consists of correction of precipitating factors, and administration of nonabsorbable disaccharides, and antibiotics. Fischer's solution improves 98% of patients with chronic recurrent type hepatic coma. Interventional radiology to reduce the blood flow from the portasystemic shunt is also effective.
戻る